The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients.

Like Comment
The I148M (rs738409-G) variant in PNPLA3 increases liver fat content but may be protective against cardiovascular disease. Insulin resistance (IR) amplifies the effect of PNPLA3-I148M on liver fat.To study whether PNPLA3-I148M confers an antihyperlipidemic effect in insulin-resistant patients.Cross-sectional study comparing the impact of PNPLA3-I148M on plasma lipids and lipoproteins in two cohorts, both divided into groups based on rs738409-G allele carrier status and median HOMA-IR.Tertiary referral center.298 obese patients who underwent a liver biopsy during bariatric surgery (Bariatric cohort; age 49±9 years, BMI 43.2±6.8 kg/m 2), and 345 less obese volunteers in whom liver fat was measured by proton magnetic resonance spectroscopy (Non-bariatric cohort; age 45±14 years, BMI 29.7±5.7 kg/m 2).Nuclear magnetic resonance profiling of plasma lipids, lipoprotein particle subclasses and their composition.In both cohorts, individuals carrying the PNPLA3-I148M variant had significantly higher liver fat content than non-carriers. In insulin-resistant and homozygous carriers, PNPLA3-I148M exerted a distinct antihyperlipidemic effect with decreased very-low-density lipoprotein (VLDL) and low-density lipoprotein particles (LDL) and their constituents, and increased high-density lipoprotein particles and their constituents, as compared to non-carriers. VLDL particles were smaller and LDL particles larger in PNPLA3-I148M carriers. These changes were geometrically opposite to those due to IR. PNPLA3-I148M did not have a measurable effect in patients with lower IR, and its effect was smaller albeit still significant in the less obese compared to the obese cohort.PNPLA3-I148M confers an antiatherogenic plasma lipid profile particularly in insulin-resistant individuals.

View the full article @ The Journal of clinical endocrinology and metabolism

Get PDF with LibKey


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6577 Contributions
0 Following